RadNet [RDNT] vs Thermo Fisher [TMO] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: RadNet Inc. wins in 2 metrics, Thermo Fisher Scientific Inc. wins in 17 metrics, with 0 ties. Thermo Fisher Scientific Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | RadNet Inc. | Thermo Fisher Scientific Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 1,425.75 | 25.84 | Thermo Fisher Scientific Inc. |
| Price-to-Book Ratio | 4.01 | 3.31 | Thermo Fisher Scientific Inc. |
| Debt-to-Equity Ratio | 137.10 | 82.91 | Thermo Fisher Scientific Inc. |
| PEG Ratio | 54.97 | 2.29 | Thermo Fisher Scientific Inc. |
| EV/EBITDA | 23.62 | 19.02 | Thermo Fisher Scientific Inc. |
| Profit Margin (TTM) | -0.91% | 15.15% | Thermo Fisher Scientific Inc. |
| Operating Margin (TTM) | 6.83% | 17.89% | Thermo Fisher Scientific Inc. |
| EBITDA Margin (TTM) | 6.83% | 17.89% | Thermo Fisher Scientific Inc. |
| Return on Equity | 1.37% | 13.52% | Thermo Fisher Scientific Inc. |
| Return on Assets (TTM) | 1.61% | 5.00% | Thermo Fisher Scientific Inc. |
| Free Cash Flow (TTM) | $85.57M | $6.29B | Thermo Fisher Scientific Inc. |
| Dividend Yield | N/A | 0.38% | N/A |
| 1-Year Return | -3.41% | 22.27% | Thermo Fisher Scientific Inc. |
| Price-to-Sales Ratio (TTM) | 2.17 | 3.86 | RadNet Inc. |
| Enterprise Value | $5.74B | $214.76B | Thermo Fisher Scientific Inc. |
| EV/Revenue Ratio | 2.81 | 4.75 | RadNet Inc. |
| Gross Profit Margin (TTM) | 13.86% | N/A | N/A |
| Revenue per Share (TTM) | $27 | $120 | Thermo Fisher Scientific Inc. |
| Earnings per Share (Diluted) | $-0.25 | $18.18 | Thermo Fisher Scientific Inc. |
| Beta (Stock Volatility) | 1.53 | 0.97 | Thermo Fisher Scientific Inc. |
| Short % of Float | 13.15% | 1.22% | Thermo Fisher Scientific Inc. |
RadNet Inc. vs Thermo Fisher Scientific Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| RadNet Inc. | -4.49% | 0.35% | -6.78% | -27.80% | -31.08% | -23.45% |
| Thermo Fisher Scientific Inc. | -1.69% | 7.56% | 4.21% | -5.21% | -16.94% | -18.64% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| RadNet Inc. | -3.41% | 82.78% | 107.98% | 955.70% | 1,150.68% | 1,855.28% |
| Thermo Fisher Scientific Inc. | 22.27% | -5.31% | 9.75% | 222.18% | 684.25% | 1,233.99% |
Performance & Financial Health Analysis: RadNet Inc. vs Thermo Fisher Scientific Inc.
| Metric | RDNT | TMO |
|---|---|---|
| Market Information | ||
| Market Cap | $4.51B | $174.55B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 789,143 | 2,356,220 |
| 90 Day Avg. Volume | 835,088 | 2,071,517 |
| Last Close | $51.87 | $473.95 |
| 52 Week Range | $50.76 - $85.84 | $385.46 - $643.99 |
| % from 52W High | -39.57% | -26.40% |
| All-Time High | $93.65 (Nov 11, 2024) | $672.34 (Dec 27, 2021) |
| % from All-Time High | -44.61% | -29.51% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.06% |
| Quarterly Earnings Growth | N/A | 0.10% |
| Financial Health | ||
| Profit Margin (TTM) | -0.01% | 0.15% |
| Operating Margin (TTM) | 0.07% | 0.18% |
| Return on Equity (TTM) | 0.01% | 0.14% |
| Debt to Equity (MRQ) | 137.10 | 82.91 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $14.08 | $141.96 |
| Cash per Share (MRQ) | $9.89 | $8.75 |
| Operating Cash Flow (TTM) | $298.82M | $8.29B |
| Levered Free Cash Flow (TTM) | $180.29M | $5.51B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.38% |
| Last 12-Month Dividend | N/A | $1.76 |
Valuation & Enterprise Metrics Analysis: RadNet Inc. vs Thermo Fisher Scientific Inc.
| Metric | RDNT (Apr 26, 2026) | TMO (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 1,425.75 | 25.84 |
| Forward P/E | 54.97 | 17.16 |
| PEG Ratio | 54.97 | 2.29 |
| Price to Sales (TTM) | 2.17 | 3.86 |
| Price to Book (MRQ) | 4.01 | 3.31 |
| Market Capitalization | ||
| Market Capitalization | $4.51B | $174.55B |
| Enterprise Value | $5.74B | $214.76B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.81 | 4.75 |
| Enterprise to EBITDA | 23.62 | 19.02 |
| Risk & Other Metrics | ||
| Beta | 1.53 | 0.97 |
| Book Value per Share (MRQ) | $14.08 | $141.96 |
Financial Statements Comparison: RadNet Inc. vs Thermo Fisher Scientific Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | RDNT (2025) | TMO (2025) |
|---|---|---|
| Revenue/Sales | 2.04B | 44.56B |
| Cost of Goods Sold | 1.80B | 26.32B |
| COGS % of Revenue | 88.5% | 59.1% |
| Gross Profit | 235.49M | 18.24B |
| Gross Margin | 11.5% | 40.9% |
| Research & Development | N/A | 1.40B |
| Operating Income (EBIT) | 83.36M | 8.11B |
| Operating Margin | 4.1% | 18.2% |
| EBITDA | 342.29M | 11.86B |
| EBITDA Margin | 16.8% | 26.6% |
| Pre-Tax Income | 31.91M | 7.31B |
| Pre-Tax Income % of Revenue | 1.6% | 16.4% |
| Income Tax | 14.86M | 547.00M |
| Income Tax % of Revenue | 0.7% | 1.2% |
| Net Income (Profit) | 17.05M | 6.72B |
| Profit Margin | 0.8% | 15.1% |
Balance Sheet & Liquidity Metrics
| Metric | RDNT (2025) | TMO (2025) |
|---|---|---|
| Cash & Equivalents | 767.22M | 9.85B |
| Total Current Assets | 1.03B | 28.71B |
| Total Current Assets % of Revenue | 50.6% | 64.4% |
| Total Current Liabilities | 586.76M | 15.19B |
| Total Current Liabilities % of Revenue | 28.8% | 34.1% |
| Long-Term Debt | 1.77B | 35.85B |
| Long-Term Debt % of Revenue | 86.8% | 80.5% |
| Total Shareholders Equity | 1.36B | 53.54B |
| Retained Earnings | -95.44M | 59.16B |
| Retained Earnings % of Revenue | -4.7% | 132.8% |
| Property, Plant & Equipment | 1.57B | 0 |
Cash Flow Statement Comparison
| Metric | RDNT (2025) | TMO (2025) |
|---|---|---|
| Operating Cash Flow | 285.58M | 7.82B |
| Operating Cash Flow % of Revenue | 14.0% | 17.5% |
| Capital Expenditures | -211.96M | -1.48B |
| Free Cash Flow | 85.57M | 6.29B |
| FCF Margin | 4.2% | 14.1% |
| Debt Repayment | -27.78M | -3.51B |
| Common Stock Repurchase | N/A | -3.00B |
Short Interest & Institutional Ownership Analysis
| Metric | RDNT | TMO |
|---|---|---|
| Shares Short | 8.66M | 4.54M |
| Short Ratio | 9.69 | 2.38 |
| Short % of Float | 13.15% | 1.22% |
| Shares Outstanding | 77.40M | 371.62M |
| Float Shares | 65.66M | 371.07M |
| % Held by Insiders | 10.02% | 0.17% |
| % Held by Institutions | 99.10% | 95.23% |
| % Held by Public | -9.12% | 4.60% |
Dividend Analysis & Yield Comparison: RadNet Inc. vs Thermo Fisher Scientific Inc.
| Metric | RDNT | TMO |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.76 |
| Last 12-Month Dividend Yield | N/A | 0.38% |
| 3-Year Avg Annual Dividend | N/A | $1.60 |
| 3-Year Avg Dividend Yield | N/A | 0.08% |
| 3-Year Total Dividends | N/A | $4.80 |
| Ex-Dividend Date | N/A | Mar 13, 2026 |